Loading...
Zhengye Biotechnology Holding Limited
ZYBT•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.55
$0.00(0.00%)
Zhengye Biotechnology Holding Limited (ZYBT) Company Profile & Overview
Explore Zhengye Biotechnology Holding Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Zhengye Biotechnology Holding Limited (ZYBT) Company Profile & Overview
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOSonglin Song
Contact Information
Company Facts
278 Employees
IPO DateJan 7, 2025
CountryCN
Actively Trading